摘要
目的观察核不均一核糖核蛋白A2/B1(hnRNPA2/B1)住非小细胞肺癌(NSCLC)中的表达及其与DNA修复酶O^6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)、8-羟基吗嘌呤DNA糖甘酶(OGGI)、氧化还原因子1(Ref-1)、DNA依赖性蛋白激酶复合物DNA—PKcs和Ku mRNA之间的相互作用,并进一步探讨其在NSCLC发病机制中的作用。方法采刚免疫绀化、Western blot及荧光实时定量PCR方法,检测NSCLC患者癌组织及正常肺组织hnRNPA2/B1的表达。采用免疫共沉淀结合逆转录聚合酶链反应(RT—PCR)方法,研究人肺鳞癌细胞株中hnRNPA2/B1蛋向是否与上述5种DNA修复酶的mRNA直接结合,然后采用免疫组化及荧光实时定量PCR方法,榆测NSCLC患者痛绀织及正常肺组织MGMT的表达情况。结果免疫组化染色显示,hnRNPA2/B1定位于细胞核,hnRNPA2/B1在NSCLC癌组织中的表达阳性率(100%)和蛋白表达评分[(5.3±0.9)分]均显著高于正常肺组织[32%和(2.2±0.7)分,P〈0.01],在Ⅲ~Ⅳ期NSCLC组织中的表达略高于J~Ⅱ期(P〈0.05),而与年龄、性别、组织学类型及吸烟状况无关(均P〉0.05)。通过tiT—PCR方法可以从人肺鳞癌细胞株免疫共沉淀产物中扩增出MGMT mRNA,提示hnRNP A2/B1与MGMT mRNA相结合。进一步的免疫组化染色结果显示,在NSCLC组织中,MGMT的表达阳性率为32.0%,明娃低于止常肺组织(78.0%),蛋白表达评分[(2.2±0.8)分]也显著低于正常肺组织[(4.1±1.2)分,P〈0.01]。荧光实时定量PCR结果显示,NSCLC组织中MGMTmRNA的表达量为1.8(0.6~3.1),明显低于正常肺组织[9.8(6.8~18.3),P〈0.01]。结论HnRNPA2/BI蛋白及mRNA在NSCI.C组织中的表达均升高,hnRNPA2/B1与MGMTmRNA相结合,可能通过对MGMTmRNA的转录后调控参与NSCLC的发牛。
Objective To study the expression of heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP A2/B1) in non-small cell lung cancer (NSCLC), and the interaction between hnRNP A2/B1 protein and mRNA of DNA repair enzymes O^6-methylguanine DNA-methyltransferase (MGMT), 8-oxoguanine DNA glycosylase ( OGG1 ), redox factor 1 ( Ref-1 ) , DNA-dependent protein kinase ( including DNA-PKcs and ku). Methods The expression and distribution of hnRNP A2/B1 were detected by immunohistochemistry and Western blot on 50 NSCLC samples from patients who underwent resection in Zhongshan Hospital. The hnRNP A2/B1 mRNA expression was tested by real-time PCR. Co- immunoprecipitation (co-IP) combined RT-PCR was used to investigate whether hnRNP A2/B1 could be bound with the mRNA of the above mentioned 5 DNA repair enzymes in human lung cancer cell line ( HTB- 182). Then immunohistochemistry and real-time PCR were used to detect the expression of MGMT in thesame group of patients. Results HnRNP A2/B1 protein and mRNA expressions were increased in the NSCLC tissues than that in the corresponding normal lung tissues. HnRNP A2/B1 was expressed predominantly in the nuclei of tumor cells. The positive rate and immunohistochemistry score of hnRNP A2/B1 in tumor tissue were significantly higher than that in normal tissue (P 〈 0.01 ). In stage m-IV NSCLC, hnRNP A2/B1 expression was higher than that in stage I-Ⅱ. There was no significant differences of hnRNP A2/BI expression among patients of different age, sex, histological type, and smoking history. The resuhs of co-IP combined RT-PCR suggested that hnRNP A2/B1 is bound with MGMT mRNA, and MGMT expression is decreased in tumor tissue of NSCLC. Conclusions The results of this study show that hnRNP A2/B1 protein and mRNA are highly expressed in NSCLC, and hnRNP A2/B1 is bound with MGMT mRNA, which indicate that it might be one of the mechanisms of hnRNP A2/B1 participating in the pathogenesis of NSCLC.
出处
《中华肿瘤杂志》
CAS
CSCD
北大核心
2011年第2期110-114,共5页
Chinese Journal of Oncology
基金
上海市复旦大学青年科学基金(154)
上海市卫生局科研课题(2009020)